New Study
Pleural mesothelioma is a cancer mainly caused by asbestos exposure. It is a cancer of the pleura, which is a lining of the lungs. The outlook for the disease is poor, with a typical survival time after diagnosis being 9 to 20 months. The overall five-year survival rate is five percent. These numbers are slightly…
Malignant pleural mesothelioma is a rare cancer associated with asbestos exposure. Two very important aspects of treating mesothelioma are classification and staging. They are important because they guide treatment and predict outcomes. One system to classify cancers is the TNM system which was created by the IASLC. It classifies cancers based on their size and…
Malignant mesothelioma is a cancer of the mesothelium, which is the lining of certain areas of the body including the lungs (called the pleura). It is mainly caused by asbestos, and usually occurs 30 to 50 years after initial asbestos exposure. Mesothelioma has a poor outlook, with most patients living only 18 months after diagnosis.…
Malignant pleural mesothelioma is an aggressive cancer mainly caused by asbestos exposure. It is a cancer of the mesothelium, which is the lining of certain areas of the body including the lungs. The cancer is aggressive and hard to treat. There is hope though in new surgical and therapy methods. A new study looks at…
Pleural mesothelioma is a cancer of the lining of the lungs called the mesothelium. It is both rare and aggressive and is linked to asbestos exposure. Patient survival is poor and there are limited treatment options for this cancer. A new study known as MARS 2 looked at surgery alongside chemotherapy to see if surgery…
The U.S Food and Drug Administration has accepted a priority review for a new Supplemental Biologics License Application. This could be a new era in the management of pleural mesothelioma, leading to a better future for those diagnosed with the cancer. The review is looking for approval of Keytruda used alongside chemotherapy. This combination could…
Malignant pleural mesothelioma is a rare cancer that is hard to treat. There is a poor prognosis for people diagnosed with mesothelioma, but there is hope in the form of immune checkpoint inhibitors. There could be a chance of better outcomes in mesothelioma patients. A new article in Open Respiratory Archives provides a historical look…
Mesothelioma, a cancer mainly caused by asbestos exposure, is typically found in older Americans. One problem with mesothelioma is that it is hard to tell between reactive and cancerous cells. A study in the American Journal of Pathology sheds light and expands on this information. The study found a biomarker, ACADL, while using advanced analysis…
Palliative care is an essential part of the cancer treatment process. It helps improve the quality of life of people with life threatening illnesses like mesothelioma. It is important for doctors to know the range of symptoms patients experience to help provide the best care possible. Palliative care is a specialty in medicine. The focus…
Mesothelioma, a cancer mainly caused by asbestos, is very hard to treat. A new study wanted to see if treating mesothelioma immediately is the best option for certain patients. The study, which was published in Clinical Lung Cancer, looks at patients with inoperable pleural mesothelioma. The study compared patients who received treatment immediately versus those…
